Illumina Ventures collects $230 mln for maiden fund
San Francisco-based Illumina Ventures, an early-stage venture firm, has raised $230 million for its debut fund. Illumina invests in early-stage companies focused on genomics and precision medicine.
16 October 2017•2 mins read
